INTERNATIONAL PATENT: ACCENT THERAPEUTICS, INC. FILES APPLICATION FOR "INHIBITORS OF THE RNA HELICASE DHX9 FOR USE IN THE TREATMENT OF DNA DAMAGE REPAIR DEFICIENT, HOMOLOGOUS RECOMBINATION DEFICIENT AND CANCERS HAVING A BRCA LOSS OF FUNCTION MUTATION"

GENEVA, April 21 -- ACCENT THERAPEUTICS, INC. (1050 Waltham StreetLexington, MA 02421) filed a patent application (PCT/US2024/050858) for "INHIBITORS OF THE RNA HELICASE DHX9 FOR USE IN THE TREATMENT OF DNA DAMAGE REPAIR DEFICIENT, HOMOLOGOUS RECOMBINATION DEFICIENT, AND CANCERS HAVING A BRCA LOSS OF FUNCTION MUTATION" on Oct 10, 2024. With publication no. WO/2025/080900, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CASTRO, Jennifer (c/o Accent Therapeutics, Inc.1050 Waltham StreetLexington, MA 02421), NAYAK, Sunaina, ...